Incyte Corp (NAS:INCY)
$ 69.91 0.07 (0.1%) Market Cap: 13.47 Bil Enterprise Value: 11.73 Bil PE Ratio: 499.36 PB Ratio: 4.25 GF Score: 89/100

Incyte Corp to Discuss Highlights from Oral PD-L1 Program from SITC Transcript

Nov 13, 2021 / 11:30PM GMT
Operator

Hello, and welcome to the Incyte Data Highlights from SITC Teleconference and Webcast. (Operator Instructions)

It's now my pleasure to turn the call over to Christine Chiou, Head of Investor Relations. Please go ahead.

Christine Chiou
Incyte Corporation - Head of IR

Thank you, Kevin. Good evening, and welcome to Incyte's Oral PD-L1 Program Highlights Conference Call and Webcast at SITC. The slides presented today are available for download on the Investors section of our website. Joining me on the call today are Herve and Steven, who will deliver our prepared remarks; and Jeff Jackson, our Vice President of Translational Sciences, who will join us for the Q&A.

Before we begin, I'd like to remind you that some of the statements made during the call today are forward-looking statements and are subject to a number of risks and uncertainties that may cause our actual results to differ materially, including those described in our 10-Q for the period ended September 30, 2021, and from time to time in our other SEC documents.

We will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot